← Back to headlines
Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising Claims
Novo Nordisk has filed a lawsuit against Eli Lilly, alleging misleading advertising claims related to GLP-1 medications.
21 Jul, 13:50 — 21 Jul, 13:50
Sources
Showing 1 of 1 sources

